Drugs for Brittle Bone Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 53)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Alendronic acid |
Approved |
Phase 4 |
|
121268-17-5, 66376-36-1 |
2088 |
Synonyms:
(4-amino-1-hydroxybutane-1,1-diyl)bis(phosphonic acid)
(4-Amino-1-hydroxybutylidene)bisphosphonate
(4-Amino-1-hydroxybutylidene)bisphosphonic acid
4 amino 1 Hydroxybutylidene 1,1 biphosphonate
4-amino-1-hydroxybutane-1,1-diphosphonic acid
4-Amino-1-hydroxybutylidene 1,1-biphosphonate
ABDP
ABDP|BPH 1|Fosamax®|MK-217
Acide alendronique
Acide Alendronique [INN-French]
Acido alendronico
Acido Alendronico [INN-Spanish]
Acidum alendronicum
Acidum Alendronicum [INN-Latin]
Adronat
Alendronate
|
Alendronate monosodium salt, trihydrate
Alendronate sodium
Alendronate sodium hydrate
Alendronic acid
Alendros
Aminohydroxybutane bisphosphonate
Arendal
BINOSTO
Bisphosphonate, aminohydroxybutane
BPH 1
Fosamax
Fosamax Plus D
G-704650
MK-217
Onclast
Sodium, alendronate
|
|
2 |
|
Teriparatide |
Approved, Investigational |
Phase 4 |
|
52232-67-4 |
16133850 155817470 |
Synonyms:
FORSTEO
Forsteo®|Forteo®|PTH-(1-34) (human)
FORTEO
LY 333334
LY333334
LY-333334
PTH (1-34)
|
PTH 1-34
PTH134
Teriparatida
Teriparatide
Teriparatide recombinant human
ZT-034
|
|
3 |
|
Pamidronic acid |
Approved |
Phase 4 |
|
40391-99-9 |
4674 |
Synonyms:
(3-Amino-1-hydroxypropylidene)-1,1-biphosphonate
(3-Amino-1-hydroxypropylidene)-1,1-bisphosphonate
1 Hydroxy 3 aminopropane 1,1 diphosphonic acid
1-Hydroxy-3-aminopropane-1,1-diphosphonic acid
ACIDE PAMIDRONIQUE
Acide pamidronique [INN-French]
ACIDO PAMIDRONICO
Acido pamidronico [INN-Spanish]
ACIDUM PAMIDRONICUM
Acidum pamidronicum [INN-Latin]
AHPrBP
Amidronate
Amino 1 hydroxypropane 1,1 diphosphonate
Amino-1-hydroxypropane-1,1-diphosphonate
Aminohydroxypropylidene diphosphonate
|
Aminomux
Aminopropanehydroxydiphosphonate
APD
ARD233
Aredia
Aredia®|CGP-23339AE|disodium pamidronate
CGP-23339AE
Novartis brand OF pamidronate disodium salt
PAMIDRONATE
Pamidronate calcium
Pamidronate disodium
Pamidronate monosodium
Pamidronic acid
Ribodroat
|
|
4 |
|
Parathyroid hormone |
Approved, Investigational |
Phase 4 |
|
9002-64-6 |
|
Synonyms:
ALX1-11
ALX-111
ALX-1-11
NPSP558
NPSP-558
Parathormone
Parathormone (human recombinant)
Parathyrin
PARATHYROID HORMONE
Parathyroid hormone (1-84) human recombinant
|
Parathyroid hormone (rDNA)
PAROIDIN
PREOTACT
PTH
PTH(1-84)
rhPTH
rhPTH(1-84)
rPTH
rPTH(1-84)
|
|
5 |
|
Risedronic acid |
Approved, Investigational |
Phase 4 |
|
105462-24-6 |
5245 |
Synonyms:
1-Hydroxy-2-(3-pyridyl)ethylidene diphosphonate
2-(3-Pyridinyl)-1-hydroxyethylidenebisphosphonate
2-(3-Pyridinyl)-1-hydroxyethylidene-bisphosphonate
Acid, risedronic
Acide risédroniqe
Acido risedronico
Acidum risedronicum
Actonel
Actonel 150
Actonel®|Atelvia®|NE-58095|risedronate sodium
Atelvia
Benet
Bisphosphate risedronate sodium
Bisphosphonate risedronate sodium
|
M05BA07
NE-58095
Ridron
Risedronate
Risedronate sodium
Risedronate sodium, bisphosphate
Risedronate sodium, bisphosphonate
Risedronic acid
Risedronic acid, monosodium salt
Risedronsäure
Sodium, bisphosphate risedronate
Sodium, bisphosphonate risedronate
Sodium, risedronate
|
|
6 |
|
Cholecalciferol |
Approved, Nutraceutical, Vet_approved |
Phase 4 |
|
67-97-0, 1406-16-2 |
5280795 10883523 |
Synonyms:
(+)-Vitamin D3
(1S,3Z)-3-[(2E)-2-[(1R,3AR,7as)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol
(1S,3Z)-3-[(2E)-2-[(1R,3AS,7AR)-1-[(1R)-1,5-DIMETHYLHEXYL]-7A-METHYL-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLENE-1-CYCLOHEXANOL
(1S,3Z)-3-[(2E)-2-[(1R,3AS,7AR)-1-[(1R)-1,5-DIMETHYLHEXYL]-7A-METHYL-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLENE-CYCLOHEXAN-1-OL
(1S,3Z)-3-[(2E)-2-[(1R,3AS,7AR)-7A-METHYL-1-[(2R)-6-METHYLHEPTAN-2-YL]-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLIDENECYCLOHEXAN-1-OL
(1S,3Z)-3-[(2E)-2-[(1R,3AS,7AR)-7A-METHYL-1-[(2R)-6-METHYLHEPTAN-2-YL]-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLIDENE-CYCLOHEXAN-1-OL
(1S,3Z)-3-{2-[(1R,4E,7AR)-7A-METHYL-1-[(2R)-6-METHYLHEPTAN-2-YL]-OCTAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE}-4-METHYLIDENECYCLOHEXAN-1-OL
(3 beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(3b,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(3beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(3BETA,Z,7E)-9,10-SECOCHOLESTA-5,7,10(19)-TRIEN-3-OL
(3Β,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(5E,7E)-9,10-SECOCHOLESTA-5,7,10-TRIEN-3-OL
(5Z,7E)-(3S)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
3-BETA,Z,7E-9,10-SECOCHOLESTR-5,7,10(19)-TRIEN-3-OL
7-DEHYDROCHOLESTEROL
9,10-SECOCHOLESTA-5,7,10(19)-TRIEN-3BETA-OL
9,10-SECOCHOLESTA-5,7,10(19)-TRIEN-3-BETA-OL
9,10-SECOCHOLESTA-5,7,10(19)-TRIEN-3-OL
9,10-SECOCHOLESTA-5,7,10-TRIEN-3-OL
ACCRETE D3
ACIFEROL D3
ACTIVATED
Activated 7-dehydrocholesterol
ADCAL-D3
ARACHITOL
AVITICOL
BIOLIFE VITAMIN D3
BIO-VITAMIN D3
CACIT D3
CALCEOS
CALCICHEW D3
CALCICHEW D3 FTE
CALCICHEW D3 ONCE DAILY
CALCI-D
Calciferol
Calciol
CALDRINK D3
CALFOVIT D3
CC
Cholecalciferol
CHOLECALCIFEROL D3
Cholecalciferols
Cholecalciferolum
COLECAL D3
Colecalciferol
Colecalciferolum
COLEKAL-D3
COLEVIT D3
CUBICOLE D3
D3 LEMON MELTS
D3-50
D3-VIGANTOL
DEKRISTOL
DELSTEROL
Delta-D
DEPARAL
DESUNIN
DEVARON
Dihydrocholesterol
DLUX 400
D-MAX
D-TRACETTEN
|
D-VIT3
EBIVIT
E-D3
EVACAL D3
FERACOL
FULTIUM DAILY D3
FULTIUM-D3
GRANUVIT D3
HUX D3
INVITA D3
ISO D3
KORA LIQUID
MICRO-DEE
NATECAL D3
NATURE'S REMEDY VITAMIN D3
NEO-D
NPHD3
NSC-375571
Oleovitamin D3
OSTEOCAPS D3
PLENACHOL
PRO D3
PRO D3 FOLIC
PRO D3 FORTE
PROVITINA
QUINTOX
RICKETON
ROYALVIT D3
STEXEROL-D3
STIVIT-D3
SUNVIT-D3 1,000
SUNVIT-D3 10,000
SUNVIT-D3 2,000
SUNVIT-D3 20,000
SUNVIT-D3 3,000
SUNVIT-D3 400
SUNVIT-D3 5,000
SUNVIT-D3 50,000
SUNVIT-D3 800
SYNERVIT-D3
THEICAL D-3
THORENS
TRIVITAN
VIDDE-3-HYDROSOL
VI-DE3
VIDEKHOL
VIGANTOL
VIGANTOLETTEN
VIGANTOLETTEN 500
VIGORSAN
VIT D3 STREULI
VITA-D3
VITAMIN D
Vitamin D 3
VITAMIN D ASSAY SYSTEM SUITABILITY
Vitamin D NOS
Vitamin D, unspecified form
Vitamin D3
Vitamin D-3
VITINC DAN-DEE-3
ZYMAD
δ-D
|
|
7 |
|
Ergocalciferol |
Approved, Nutraceutical |
Phase 4 |
|
50-14-6 |
5280793 |
Synonyms:
(+)-Vitamin D2
(1S,3Z)-3-[(2E)-2-[(1R,3AS,7AR)-1-[(E,2R,5R)-5,6-DIMETHYLHEPT-3-EN-2-YL]-7A-METHYL-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLIDENECYCLOHEXAN-1-OL
(1S,3Z)-3-[(2E)-2-[(1R,3AS,7AR)-1-[(E,2R,5R)-5,6-DIMETHYLHEPT-3-EN-2-YL]-7A-METHYL-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLIDENE-CYCLOHEXAN-1-OL
(1S,3Z)-3-[(2E)-2-[(1R,3AS,7AR)-7A-METHYL-1-[(E,1R,4R)-1,4,5-TRIMETHYLHEX-2-ENYL]-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLENE-1-CYCLOHEXANOL
(1S,3Z)-3-[(2E)-2-[(1R,3AS,7AR)-7A-METHYL-1-[(E,1R,4R)-1,4,5-TRIMETHYLHEX-2-ENYL]-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLENE-CYCLOHEXAN-1-OL
(1S,3Z)-3-{2-[(1R,3AS,4E,7AR)-1-[(2R,3E,5R)-5,6-DIMETHYLHEPT-3-EN-2-YL]-7A-METHYL-OCTAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE}-4-METHYLIDENECYCLOHEXAN-1-OL
(3b,5Z,7E,22E)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
(3beta,5Z,7E,22E)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
(3Β,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(5E,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
22-Tetraen 3beta 9,10,secoergosta-5,7,10(19)-ol
4-Methylene-3-[2-[tetrahydro-7a-methyl-1-(1,4,5-trimethyl-2-hexenyl)-4(3ah)-indanylidene]ethylidene]-cyclohexanol
9,10-Secoergosta-5,7,10(19),22-tetraen-3b-ol
Activated ergosterol
beta-Ol
Buco-D
Calciferol
CALCIFEROL IN ARACH OIL
Calciferols
Calciferon 2
CALTRATE
Condacaps
Condocaps
Condol
Crtron
Crystallina
D2, Vitamin
Daral
D-Arthin
Davitamon D
Davitin
Decaps
Dee-osterol
Dee-ron
Dee-ronal
Dee-roual
delta-Arthin
Deltalin
delta-Tracetten
De-rat concentrate
Deratol
Detalup
D-FORTE
Diactol
Divit urto
Doral
Drisdol
D-Tracetten
ECIFEROL D2
Ercalciol
|
Ergocalciferol
ERGOCALCIFÉROL
Ergocalciferol oil
Ergocalciferols
Ergocalciferolum
ERGO-D2
ERGORAL D2
Ergorone
Ergosterol activated
Ergosterol irradiated
Ertron
Fortodyl
Geltabs
Hi-deratol
Infron
Irradiated ergosta-5,7,22-trien-3beta-ol
LANES
Metadee
Mina D2
Mulsiferol
Mykostin
Novovitamin-D
NSC-62792
Oleovitamin D
OLEOVITAMIN D, SYNTHETIC
Oleovitamin D2
Osteil
Ostelin
OSTO-D2
Radiostol
Radstein
Radsterin
Rodine C
Shock-ferol
Shock-ferol sterogyl
Sterogyl
STEROGYL 15H
STEROGYL-15
Synthetic vitamin D
Uvesterol D
Uvesterol-D
Vio D
Vio-D
Viostdrol
Viosterol
Viosterol in oil
VITAMIN D
Vitamin D 2
Vitamin D2
Vitamina D2
Vitavel-D
|
|
8 |
|
Vitamins |
|
Phase 4 |
|
|
|
9 |
|
Trace Elements |
|
Phase 4 |
|
|
|
10 |
|
Calciferol |
|
Phase 4 |
|
|
|
11 |
|
Micronutrients |
|
Phase 4 |
|
|
|
12 |
|
Vitamin D2 |
|
Phase 4 |
|
|
3249 |
Synonyms:
Calciferols
D2, Vitamin
Ergocalciferol
|
Ergocalciferols
Vitamin D 2
Vitamin D2
|
|
13 |
|
Ergocalciferols |
|
Phase 4 |
|
|
|
14 |
|
Calcium, Dietary |
|
Phase 4 |
|
|
|
15 |
|
calcium channel blockers |
|
Phase 4 |
|
|
|
16 |
|
Calcium |
Nutraceutical |
Phase 4 |
|
7440-70-2 |
271 |
Synonyms:
Ca
Ca(2+)
Ca2+
Calcio
CALCIUM
Calcium element
|
CALCIUM ion
Calcium(2+)
Calcium, doubly charged positive ion
Calcium, elemental
Elemental calcium
Kalzium
|
|
17 |
|
Denosumab |
Approved |
Phase 3 |
|
615258-40-7 |
|
Synonyms:
AMG-162
Denosumab
PROLIA
PROLIA, RANMARK XGEVA
|
PROLIA, XGEVA
TK006
TK-006
XGEVA
|
|
18 |
|
Pharmaceutical Solutions |
|
Phase 2, Phase 3 |
|
|
|
19 |
|
Immunoglobulins |
|
Phase 2, Phase 3 |
|
|
|
20 |
|
Antibodies, Monoclonal |
|
Phase 2, Phase 3 |
|
|
|
21 |
|
Antibodies |
|
Phase 2, Phase 3 |
|
|
|
22 |
|
Calcium carbonate |
Approved, Investigational |
Phase 2 |
|
471-34-1 |
|
Synonyms:
Aragonite
CaCO3
Calcio carbonato
Calcite
Calcium carbonate
Calcium carbonate (1:1)
Calcium carbonate, precipitated
Calcium carbonic acid
Calcium carbonic acid (1:1)
Calcium carbonic acid, precipitated
Calcium milk
Calciumcarbonat
Cal-sup
Carbonate calcium salt (1:1)
Carbonate de calcium
|
Carbonate, calcium
Carbonato de calcio
Carbonic acid calcium salt (1:1)
Carbonic acid de calcium
Chalk
e 170
Kalziumkarbonat
Kohlensaurer kalk
Limestone
Marble
Milk OF calcium
Precipitated calcium carbonate
Precipitated calcium carbonic acid
Vaterite
|
|
23 |
|
Zoledronic acid |
Approved |
Phase 2 |
|
118072-93-8 |
68740 |
Synonyms:
(1-Hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonate
(1-Hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid
(1-Hydroxy-2-imidazol-1-ylethylidene)diphosphonate
(1-Hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid
2-(Imidazol-1-yl)-1-hydroxyethylidene-1,1-bisphosphonic acid
ácido zoledrónico
ACLASTA
Aclasta®|CGP-42446|CGP-42446A|Reclast®|zoledronate|Zometa®
ANHYDROUS ZOLEDRONIC ACID
CGP-42446
CGP-42446A
Novartis brand OF zoledronic acid
|
Reclast
ZERLINDA
ZOL
ZOL446
ZOLEDRONATE
Zoledronic acid
Zoledronic acid anhydrous
ZOLEDRONIC ACID HYDRATE
ZOLEDRONIC ACID MONOHYDRATE
ZOLEDRONIC ACID, ANHYDROUS
Zometa
Zometa Concentrate
|
|
24 |
|
Liver Extracts |
|
Phase 1, Phase 2 |
|
|
|
25 |
|
Busulfan |
Approved, Investigational |
Phase 1 |
|
55-98-1 |
2478 |
Synonyms:
1,4-Bis(methanesulfonoxy)butane
1,4-Bis(methanesulphonoxy)butane
1,4-Butanediol dimethanesulfonate
1,4-Butanediol dimethanesulfonic acid
1,4-Butanediol dimethanesulphonate
1,4-Butanediol dimethanesulphonic acid
1,4-Dimesyloxybutane
1,4-Dimethanesulfonoxybutane
1,4-Dimethanesulphonoxybutane
Bisulfex
Bisulphex
BUSILVEX
BUSULFAN
Busulfan glaxosmithkline brand
Busulfan orphan brand
Busulfan wellcome
Busulfan wellcome brand
Busulfano
Busulfanum
Busulfex
BUSULFEX IV
Busulphan
Busulphane
Busulphano
Busulphanum
Butanedioldimethanesulfonate
Buzulfan
Citosulfan
Glaxo wellcome brand OF busulfan
GlaxoSmithKline brand OF busulfan
Glyzophrol
Leucosulfan
|
Leucosulphan
Mablin
Mielevcin
Mielosan
Mielucin
Milecitan
Mileran
Misulban
Mitosan
Mitostan
Myeleukon
Myeloleukon
Myelosan
Mylecytan
Myleran
Myléran
Myleran Tablets
N-Butane-1,3-di(methylsulfonate)
NCI-C01592
NSC-750
Orphan brand OF busulfan
Sulfabutin
Sulphabutin
Tetramethylene bis(methanesulfonate)
Tetramethylene bis(methanesulfonic acid)
Tetramethylene bis(methanesulphonate)
Tetramethylene bis(methanesulphonic acid)
Tetramethylene dimethane sulfonate
Tetramethylenester kyseliny methansulfonove
Wellcome brand OF busulfan
Wellcome, busulfan
|
|
26 |
|
Cyclophosphamide |
Approved, Investigational |
Phase 1 |
|
50-18-0, 6055-19-2 |
2907 |
Synonyms:
(+-)-Cyclophosphamide
(+,-)-2-(Bis(2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide monohydrate
(RS)-Cyclophosphamide
2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide
Anhydrous cyclophosphamide
Anhydrous, cyclophosphamide
ASTA
Asta B 518
Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester
Ciclofosfamida
Ciclofosfamide
Clafen
Claphene
CP
CPA
CTX
CY
Cyclophosphamid
Cyclophosphamide
Cyclophosphamide anhydrous
Cyclophosphamide monohydrate
Cyclophosphamide Sterile
Cyclophosphamide, (R)-isomer
Cyclophosphamide, (S)-isomer
Cyclophosphamidum
Cyclophosphan
Cyclophosphane
Cyclophosphoramide
|
Cyclostin
Cyklofosfamid
Cytophosphan
Cytophosphane
Cytoxan
Cytoxan Lyoph
Endoxan
Endoxan R
Endoxana
Endoxanal
Endoxan-Asta
Endoxane
Enduxan
Genoxal
Hexadrin
LEDOXINA
Lyophilized Cytoxan
Mitoxan
Monohydrate, cyclophosphamide
N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
Neosar
Procytox
Rcra Waste Number U058
Revimmune
Semdoxan
Sendoxan
Senduxan
Zyklophosphamid
|
|
27 |
|
Miconazole |
Approved, Investigational, Vet_approved |
Phase 1 |
|
22916-47-8 |
4189 |
Synonyms:
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
Brentan
CONOFITE
Dactarin
DERMAZOLE
DUMICOAT
Esteve brand OF miconazole
florid(nitrate)|Monistat®|R-14889
Janssen cilag brand OF miconazole
Janssen-cilag brand OF miconazole
Johnston and johnston brand OF miconazole nitrate
LORAMYC
MCZ
MICATIN
|
Miconasil nitrate
Miconazol
Miconazole
Miconazole esteve brand
Miconazole janssen-cilag brand
Miconazole nitrate
Miconazolum
Monistat
MONISTAT-3
MONISTAT-DERM
Nitrate, miconasil
Nitrate, miconazole
NSC-170986
Oravig
VUSION
|
|
28 |
|
Clotrimazole |
Approved, Vet_approved |
Phase 1 |
|
23593-75-1 |
2812 |
Synonyms:
(Chlorotrityl)imidazole
1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole
1-(a-(2-Chlorophenyl)benzhydryl)imidazole
1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole
1-(O-Chloro-a,a-diphenylbenzyl)imidazole
1-(O-Chloro-alpha,alpha-diphenylbenzyl)imidazole
1-(O-Chlorotrityl)imidazole
1-(O-Chloro-α,α-diphenylbenzyl)imidazole
1-(Α-(2-chlorophenyl)benzhydryl)imidazole
ABTRIM
ACTAVALL
Bay b 5097
BAY-5097
Bayer brand 1 OF clotrimazole
Bayer brand 2 OF clotrimazole
CANDIDEN
Canesten
Canesten 1-day cream combi-pak
Canesten 1-day therapy
Canesten 3-day therapy
Canesten 6-day therapy
CANESTEN AF
Canesten combi-pak 1-day therapy
Canesten combi-pak 3-day therapy
Canesten cream
CANESTEN CRM COMBI
CANESTEN INTERNAL
Canesten solution
CANESTEN VC
Canesten®|Lotrimin®
Canestine
Chlotrimazole
Clotrimaderm
Clotrimaderm cream
Clotrimazol
CLOTRIMAZOLE
Clotrimazole schering brand
Clotrimazolum
Desamix F
Empecid
FB b 5097
Fem care
FemCare
FUNGEDERM
GNF-PF-3499
Gyne lotrimin
Gyne-lotrimin
Gyne-lotrimin 3
Gyne-lotrimin 3 combination pack
Gyne-lotrimin combination pack
Gyne-lotrimin3
Gyne-lotrimin3 combination pack
|
Gynix
Kanesten
Klotrimazole
Lopac-C-6019
Lotrimax
Lotrimin
LOTRIMIN (TN)
Lotrimin af
Lotrimin af cream
Lotrimin af jock-itch cream
Lotrimin af lotion
Lotrimin af solution
Lotrimin cream
Lotrimin lotion
Lotrimin solution
Lotrisone
MASNODERM
mono-Baycuten
Monobaycuten
Mycelax
Mycelex
MYCELEX (TN)
Mycelex 7
Mycelex cream
Mycelex g
Mycelex otc
Mycelex solution
Mycelex troches
Mycelex twin pack
Mycelex: mycosporinrimazole
Mycelex-7
Mycelex-7 combination pack
Mycelex-g
MYCIL GOLD
Myclo cream
Myclo solution
Myclo spray solution
Myclo-gyne
Mycosporin
Mykosporin
Neo-zol cream
NSC-257473
Otomax
Pedisafe
Prestwick_120
PRIVACOM
Rimazole
Schering brand OF clotrimazole
Tibatin
Trimysten
Trivagizole 3
Veltrim
|
|
29 |
|
Antirheumatic Agents |
|
Phase 1 |
|
|
|
30 |
|
Alkylating Agents |
|
Phase 1 |
|
|
|
31 |
|
Antineoplastic Agents, Alkylating |
|
Phase 1 |
|
|
|
32 |
|
Anti-Infective Agents |
|
Phase 1 |
|
|
|
33 |
|
Calcineurin Inhibitors |
|
Phase 1 |
|
|
|
34 |
|
Cyclosporins |
|
Phase 1 |
|
|
|
35 |
|
Antifungal Agents |
|
Phase 1 |
|
|
|
36 |
|
Immunosuppressive Agents |
|
Phase 1 |
|
|
|
37 |
|
Dermatologic Agents |
|
Phase 1 |
|
|
|
38 |
|
Immunologic Factors |
|
Phase 1 |
|
|
|
39 |
|
Lithium carbonate |
Approved |
|
|
554-13-2 |
|
Synonyms:
CAMCOLIT 250
CAMCOLIT 400
Carbonic acid, dilithium salt
CP-1546761
CP-15467-61
Dilithium carbonate
ESKALITH
ESKALITH CR
LISKONUM
|
LITHANE
Lithii carbonas
LITHIUM CARBONATE
LITHOBID
LITHONATE
LITHOTABS
NSC-16895
PHASAL
|
|
40 |
|
Sodium citrate |
Approved, Investigational |
|
|
68-04-2 |
23431961 |
Synonyms:
Anhydrous sodium citrate
Anhydrous trisodium citrate
Citric acid, trisodium salt
Natrii citras
Natrocitral
Sodium citrate anhydrous
Sodium citrate, anhydrous
|
Sodium citrate,anhydrous
Sodium citric acid
Trisodium 2-hydroxypropane-1,2,3-tricarboxylate
trisodium citrate anhydrous
Trisodium citrate, anhydrous
Trisodium-citrate
|
|
41 |
|
Tranexamic acid |
Approved |
|
|
1197-18-8 |
5526 |
Synonyms:
(1R,4R)-4-(AMINOMETHYL)CYCLOHEXANE-1-CARBOXYLIC ACID
Acide tranexamique
Acide tranéxamique
Acido tranexamico
ácido tranexámico
Acidum tranexamicum
CL-65336
CL-65336|Cyclo-F®|Cyklokapron®|Femstrual®|trans AMCHA
CYCLO-F
CYKLO-F HEAVY PERIOD RELIEF
Cyklokapron
EXACYL
FEMSTRUAL
LB1148
LB-1148
LYSTEDA
MENSTRALITE
|
NSC-291305
RP-18429
Tranexamate
Tranexamic acid
Tranexamsaeure
Tranexmate
Tranexmic acid
Tranhexamate
Tranhexamic acid
trans AMCHA
trans-4-(Aminomethyl)cyclohexanecarboxylate
trans-4-(Aminomethyl)cyclohexanecarboxylic acid
trans-4-AMINOMETHYLCYCLOHEXANE-1-carboxylate
trans-4-AMINOMETHYLCYCLOHEXANE-1-carboxylIC ACID
trans-Amcha
trans-Tranexamate
trans-Tranexamic acid
|
|
42 |
|
Citric acid |
Approved, Nutraceutical, Vet_approved |
|
|
77-92-9 |
311 |
Synonyms:
2-hydroxy-1,2,3-propanetricarboxyic acid
2-Hydroxy-1,2,3-propanetricarboxylate
2-Hydroxy-1,2,3-propanetricarboxylic acid
2-Hydroxytricarballylate
2-Hydroxytricarballylic acid
3-Carboxy-3-hydroxypentane-1,5-dioate
3-Carboxy-3-hydroxypentane-1,5-dioic acid
Acid monohydrate, citric
ácido cítrico
Acidum citricum
Aciletten
Anhydrous citrate
Anhydrous citric acid
beta-Hydroxytricarballylate
beta-Hydroxytricarballylic acid
Chemfill
Citraclean
Citrate
Citrate anhydrous
Citretten
CITRIC ACID
Citric acid anhydrous
CITRIC ACID HYDRATE
Citric acid monoglyceride
|
Citric acid monohydrate
Citric acid, anhydrous
Citric acid,anhydrous
Citro
Citronensaeure
Citronensäure
e 330
e330
E-330
FEMA NO. 2306
H3Cit
Hydrocerol a
INS NO.330
INS-330
Kyselina citronova
Monohydrate, citric acid
NSC-112226
NSC-30279
NSC-626579
Suby g
Uralyt u
UROLOGIC G
Uro-trainer
|
|
43 |
|
Calcifediol |
Approved, Nutraceutical |
|
|
19356-17-3 |
5283731 |
Synonyms:
(1S,3Z)-3-{2-[(1R,3AS,4E,7AR)-1-[(2R)-6-HYDROXY-6-METHYLHEPTAN-2-YL]-7A-METHYL-OCTAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE}-4-METHYLIDENECYCLOHEXAN-1-OL
(3b,5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-3,25-diol
(3beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-3,25-diol
(3S,5Z,7E)-9,10-Seco-5,7,10(19)-cholestatriene-3,25-diol
(3S,5Z,7E)-9,10-Secocholesta-5,7,10-triene-3,25-diol
(3Β,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-3,25-diol
(5Z,7E)-(3S)-9,10-Secocholesta-5,7,10(19)-triene-3,25-diol
25 Hydroxycholecalciferol
25 Hydroxycholecalciferol monohydrate
25 Hydroxyvitamin D 3
25 Hydroxyvitamin D3
25(OH)D
25(OH)D3
25-Hydroxycholecalciferol
25-Hydroxy-cholecalciferol
25-Hydroxycholecalciferol monohydrate
25-Hydroxyvitamin D 3
25-Hydroxyvitamin D3
3-{2-[1-(5-hydroxy-1,5-dimethyl-hexyl)-7a-methyl-octahydro-inden-4-ylidene]-ethylidene}-4-methylene-cyclohexanol
5,6-cis-25-Hydroxyvitamin D3
9,10-Secocholesta-5,7,10(19)-triene-3b,25-diol
Anhydrous, calcifediol
|
Aventis brand OF calcifediol
Calcidiol
Calcifediol
Calcifédiol
Calcifediol anhydrous
Calcifediol aventis brand
Calcifediol faes brand
Calcifediol organon brand
Calcifediol, (3 alpha,5Z,7E)-isomer
Calcifediol, (3 beta,5E,7E)-isomer
Calcifediolum
Calderol
Dedrogyl
Didrogyl
Faes brand OF calcifediol
Hidroferol
Monohydrate, 25-hydroxycholecalciferol
Organon brand OF calcifediol
Rayaldee
RYALDEE
U-32070E
|
|
44 |
|
Psychotropic Drugs |
|
|
|
|
|
45 |
|
Antidepressive Agents |
|
|
|
|
|
46 |
|
Citrate |
|
|
|
|
|
47 |
|
Diphosphonates |
|
|
|
|
|
48 |
|
Anabolic Agents |
|
|
|
|
|
49 |
|
Hydroxycholecalciferols |
|
|
|
|
|
50 |
|
Antifibrinolytic Agents |
|
|
|
|
|
Interventional clinical trials:
(show top 50)
(show all 64)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Efficacy and Safety of Alendronate in Chinese Children or Adolescents With Osteogenesis Imperfecta: an Age Stratified Prospective Study |
Completed |
NCT02303873 |
Phase 4 |
Alendronate |
2 |
Bisphosphonate Therapy for Osteogenesis Imperfecta |
Completed |
NCT00159419 |
Phase 4 |
Alendronate;Pamidronate |
3 |
A Study to Assess the Effectiveness of Teriparatide (FORTEO) for Increasing Bone Mass and Improving Bone Strength in Adults Affected With Osteogenesis Imperfecta (OI) |
Completed |
NCT00131469 |
Phase 4 |
Teriparatide (FORTEO);Placebos |
4 |
Effect of High-Dose Vitamin D on Bone Density in Osteogenesis Imperfecta |
Completed |
NCT01713231 |
Phase 4 |
|
5 |
Treatment of Osteogenesis Imperfecta With Parathyroid Hormone and Zoledronic Acid |
Recruiting |
NCT03735537 |
Phase 4 |
Teriparatide Pen Injector;Zoledronic Acid |
6 |
Effects of Bisphosphonates on OI-Related Hearing Loss: A Pilot Study |
Recruiting |
NCT04152551 |
Phase 4 |
Risedronate Oral Tablet |
7 |
Safety and Efficacy of Risedronate in the Treatment of Osteogenesis Imperfecta in Children |
Completed |
NCT00106028 |
Phase 3 |
risedronate sodium (Actonel);Placebo |
8 |
A Trial of Pamidronate in Children With Osteogenesis Imperfecta |
Completed |
NCT00005901 |
Phase 3 |
Pamidronate (Aredia) |
9 |
An International, Multicenter, Open-label, Efficacy and Safety Trial of Intravenous Zoledronic Acid in Infants Less Than One Year of Age, With Severe Osteogenesis Imperfecta |
Completed |
NCT00982124 |
Phase 3 |
Zoledronic Acid |
10 |
Multicenter, Single-arm Open-label Extension Study to Assess Long-term Safety and Efficacy of Current or Prior Treatment With Denosumab in Children/Young Adults With Osteogenesis Imperfecta |
Completed |
NCT03638128 |
Phase 3 |
Denosumab;Alternative osteoporosis medications |
11 |
Studies of Growth Deficiency and Growth Hormone Treatment in Children With Osteogenesis Imperfecta Types III and IV |
Completed |
NCT00001305 |
Phase 3 |
Humatrope |
12 |
To Evaluate the Effect of Denosumab in Lumbar Spine Bone Mineral Density (BMD) Z-score at 12 Months, as Assessed by Dual-energy X-ray Absorptiometry (DXA), in Children 2 to 17 Years of Age (at the Time of Screening) on a 3-Month Dosing Regimen With OI |
Completed |
NCT02352753 |
Phase 3 |
Denosumab |
13 |
An Operationally Seamless, Randomized Phase 2/3 Study Consisting of a Phase 2 Single-Blind, Dose-Evaluation Phase and a Phase 3 Double-Blind, Placebo-Controlled Phase to Assess the Efficacy and Safety of Setrusumab in Subjects With Osteogenesis Imperfecta |
Recruiting |
NCT05125809 |
Phase 2, Phase 3 |
|
14 |
Exploratory, Open Label, Multiple Dose, Phase I/II Trial Evaluating Safety, Efficacy of Intravenous and Intraosseous Infusion of Allogeneic Fetal Mesenchymal Stem In Treatment of Severe Osteogenesis Imperfecta Compared With Historical and Untreated Prospective Controls |
Unknown status |
NCT04623606 |
Phase 1, Phase 2 |
|
15 |
A Phase 2b, Multicentre, Multinational, Double-blind, Dose-finding Study, Incorporating an Open Label Substudy, in Adult Patients With Type I, III or IV Osteogenesis Imperfecta Treated With Setrusumab (BPS804) |
Completed |
NCT03118570 |
Phase 2 |
setrusumab;zoledronic acid (optional) |
16 |
Efficacy and Safety of Zoledronic Acid in Children (1 -17 Years) With Severe Osteogenesis Imperfecta |
Completed |
NCT00131118 |
Phase 2 |
Zoledronic Acid |
17 |
Do Bisphosphonates Alter the Skeletal Response to Mechanical Stimulation in Children With Osteogenesis Imperfecta? |
Completed |
NCT03208582 |
Phase 2 |
Risedronate Sodium |
18 |
Bisphosphonate Treatment of Osteogenesis Imperfecta |
Completed |
NCT00063479 |
Phase 2 |
Zoledronic Acid |
19 |
TRANSLATIONAL THERAPY IN PATIENTS WITH OSTEOGENESIS IMPERFECTA - A PILOT TRIAL ON TREATMENT WITH THE RANKL-ANTIBODY DENOSUMAB |
Completed |
NCT01799798 |
Phase 2 |
Denosumab |
20 |
A Randomized, Open Label Intra-patient Dose Escalation Study With an Untreated Reference Group to Evaluate Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Infusions of BPS804 in Adults With Moderate Osteogenesis Imperfecta |
Completed |
NCT01417091 |
Phase 2 |
BPS804 |
21 |
An Exploratory, Open Label, Multiple Dose, Multicentre Phase I/II Trial Evaluating Safety and Efficacy of Postnatal or Prenatal and Postnatal Intravenous Administration of Allogeneic Expanded Fetal Mesenchymal Stem Cells for the Treatment of Severe Osteogenesis Imperfecta Compared With a Combination of Historical and Untreated Prospective Controls |
Active, not recruiting |
NCT03706482 |
Phase 1, Phase 2 |
|
22 |
A Phase 1/2 Study to Examine the Safety and Preliminary Efficacy of Mesenchymal Stromal Cells on Linear Growth and Bone Health Parameters in Children With Type 3 Osteogenesis Imperfecta (OI) |
Not yet recruiting |
NCT05559801 |
Phase 1, Phase 2 |
Bone marrow-derived mesenchymal stromal cells (MSCs) |
23 |
A Phase 2b, Multicenter, Long-term Extension Study of Setrusumab in Adults With Type I, III, or IV Osteogenesis Imperfecta |
Terminated |
NCT05312697 |
Phase 2 |
|
24 |
The Effect of Treatment With Teriparatide and Zoledronic Acid in Patients With Osteogenesis Imperfecta |
Terminated |
NCT01679080 |
Phase 2 |
Zoledronic acid;Teriparatide |
25 |
A Phase 2, Non-controlled, Open-Label, Exploratory Study of BPS804 Treatment in Adult Patients With Type I, III or IV Osteogenesis Imperfecta |
Withdrawn |
NCT03216486 |
Phase 2 |
BPS804 |
26 |
A Pilot Study to Assess the Safety and Feasibility of Repeated Infusions of Mesenchymal Stromal Cells (MSC) in Children With Osteogenesis Imperfecta |
Completed |
NCT01061099 |
Phase 1 |
|
27 |
Multicenter Study to Evaluate Safety of Fresolimumab in Adults With Moderate-to-severe Osteogenesis Imperfecta |
Completed |
NCT03064074 |
Phase 1 |
Fresolimumab |
28 |
Treatment of Severe (Types II and III) Osteogenesis Imperfecta by Allogeneic Bone Marrow Transplantation |
Completed |
NCT00705120 |
Phase 1 |
Cyclophosphamide;Cyclosporin;Busulfan |
29 |
Mesenchymal Stem Cell Based Therapy for the Treatment of Osteogenesis Imperfecta |
Completed |
NCT02172885 |
Phase 1 |
|
30 |
A Phase 1b, Single Ascending Dose, Randomized, Double-blind Study to Evaluate the Safety, Tolerability, and Activity of SAR439459 in Adults With Osteogenesis Imperfecta |
Recruiting |
NCT05231668 |
Phase 1 |
SAR439459;Placebo |
31 |
An Open-label, Ascending Multiple-dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Romosozumab in Children and Adolescents With Osteogenesis Imperfecta |
Active, not recruiting |
NCT04545554 |
Phase 1 |
Romosozumab |
32 |
Evaluation of the Benefits of Adaptive Physical Activity in Children and Adolescents With Osteogenesis Imperfecta |
Unknown status |
NCT04119388 |
|
|
33 |
Molecular Genetic Study of Suspected Cases of Osteogenesis Imperfecta Attending Assiut University Children Hospital |
Unknown status |
NCT03169192 |
|
Zoledronic Acid |
34 |
Preventive Fixation of Lower Limbs in Osteogenesis Imperfecta (Brittle Bone Disease) With the Highlight of the Fassier-Duval |
Unknown status |
NCT02868294 |
|
|
35 |
Rare Diseases Clinical Research Network Brittle Bone Disorders Consortium Osteogenesis Imperfecta (OI) Quality of Life Survey Pilot Project 2 |
Completed |
NCT02793063 |
|
|
36 |
Pregnancy in Osteogenesis Imperfecta (OI) Registry |
Completed |
NCT03072303 |
|
|
37 |
Calcium Intake Improvement After Nutritional Intervention in Pediatric Patients With Osteogenesis Imperfecta |
Completed |
NCT03841188 |
|
|
38 |
High Resolution Thermal Imaging to Identify Vertebral Fractures in Children and Young People With Osteogenesis Imperfecta |
Completed |
NCT04231916 |
|
|
39 |
Whole Body Vibration as an Osteogenic Treatment for Children With Osteogenesis Imperfecta With Limited Mobility: A Randomised Controlled Pilot Trial |
Completed |
NCT03029312 |
|
|
40 |
Evaluation and Intervention for Ambulation, Growth, and Basilar Invagination in Osteogenesis Imperfecta |
Completed |
NCT00001594 |
|
|
41 |
Marrow Mesenchymal Cell Therapy for Osteogenesis Imperfecta: A Pilot Study |
Completed |
NCT00187018 |
|
|
42 |
Prevention of Post Operative Bone Loss in Children |
Completed |
NCT00655681 |
|
pamidronate |
43 |
Experimental Evaluation of Back Braces for the Treatment of Spinal Deformity Produced With 3D Printing Technology |
Completed |
NCT04282408 |
|
|
44 |
NGS Strategy Effectiveness in Molecular Diagnosis |
Completed |
NCT03557567 |
|
|
45 |
Trial of Lithium Carbonate for Treatment of Osteoporosis Pseudoglioma Syndrome |
Completed |
NCT01108068 |
|
Lithium |
46 |
Non-invasive Blood Pressuring Monitoring in Patients With Osteogenesis Imperfecta: Does Circumferential Cuff Pressure Result in Fractures? |
Recruiting |
NCT04169568 |
|
|
47 |
Registry of Osteogenesis Imperfecta That Collects Clinical, Functional, Genetic, Genealogical, Imaging, Surgical, Quality of Life Data. Data Are Linked to Patients Biological Sample |
Recruiting |
NCT04115774 |
|
bisphosphonates |
48 |
A Natural History of the Collagen-Related Disorder Osteogenesis Imperfecta and the Genotype-Phenotype Correlation |
Recruiting |
NCT03575221 |
|
|
49 |
Rare Diseases Clinical Research Network Brittle Bone Disease Consortium Longitudinal Study of Osteogenesis Imperfecta |
Recruiting |
NCT02432625 |
|
|
50 |
Use of Clear Aligners for the Treatment of Dental Malocclusion in Individuals With Osteogenesis Imperfecta Types III and IV |
Recruiting |
NCT04815564 |
|
|
Inferred drug relations via
UMLS
71
/
NDF-RT
50
:
Calcitonin
|
salmon calcitonin
|
|